:: Homepage

CRC recommended chemicals for inclusion in Annex III

Introduction
            The Chemical Review Committee meets annually (generally in February or March) while the Conference of the Party meets every two years (generally October). There is thus potentially as much as 18 months between the completion of the decision guidance document by the Chemical Review Committee and consideration of the recommendation for listing in Annex III by the Conference of the Parties. In cases where the Conference of the Parties is unable to take a decision on its first consideration of a recommendation of the Chemical Review Committee, the time between the conclusion of the work of the Chemical Review Committee and a further consideration by the Conference of the Parties can be in the order of 3.5 years.
            In the interest of promoting information exchange among Parties on these chemicals during this interim period the notifications of final regulatory action, relevant supporting documentation, rationale developed by the Chemical Review Committee and draft decision guidance document, are collected here for the individual chemicals.
The Chemical Review Committee (CRC) has recommended the following chemicals for listing in Annex III. For each of these chemicals the recommendation of the CRC, the associated rationale as well as the draft decision guidance document (DGD) and information available to the CRC are provided below.
            The following chemicals are scheduled for consideration for inclusion in Annex III of the Convention by the Conference of the Parties' Fifth Meeting (COP5) in June 2011:
 
            The following chemicals are scheduled for consideration for inclusion in Annex III of the Convention by the Conference of the Parties' Sixth Meeting (COP6) in 2013:
 
- Azinphos-methyl
- Perfluorooctane sulfonic acid, its salts and the precursor perfluorooctane sulfonyl fluoride
- TetraBDE and PentaBDE contained in pentabromodiphenyl ether commercial mixtures
- HexaBDE; heptaBDE; octaBDE; nonaBDE; and decaBDE contained in octabromodiphenyl ether commercial mixtures
 

 

:: top